Filing Details
- Accession Number:
- 0001818382-23-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-16 16:04:40
- Reporting Period:
- 2023-06-15
- Accepted Time:
- 2023-06-16 16:04:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818382 | Humacyte Inc. | HUMA | Biological Products, (No Disgnostic Substances) (2836) | 851763759 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1878020 | W Brady Dougan | 2525 East North Carolina Highway 54 Durham NC 27713 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-06-15 | 500,000 | $3.12 | 9,990,736 | No | 4 | S | Indirect | By Ayabudge LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Ayabudge LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 510,161 | Direct | |
| Common Stock | 1,270,240 | Indirect | By spouse |
Footnotes
- The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.
Billionaire Hedge Funds
